About Certara™

Certara is dedicated to improving human health through a broad spectrum of products and services, from molecular discovery to clinical research. Formed in 2008, Certara unites Tripos and Pharsight Corporation.

Tripos provides innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Pharsight provides software and scientific services to improve productivity and decision-making in clinical drug development.

Certara focuses on reducing the barriers between the phases of research to speed discoveries in chemistry and enables pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.

To learn more about the companies comprising Certara, simply click on their respective logos.